KEYMED BIO-B(02162): Wang Minchuan resigned as a non-executive director.
Kangnuoya-B (02162) announced that Dr. Wang Minchuan has submitted his resignation and will resign from the position of non-executive director of the company, effective September 4, 2026.
KEYMED BIO-B (02162) announced that Dr. Wang Minchuan has submitted his resignation, resigning from his position as a non-executive director of the company, effective September 4, 2026.
Related Articles
ZHIHU-W (02390) plans to invest 1.5 billion yuan to subscribe for limited partnership equity in a fund to deepen its understanding of the evolution of artificial intelligence technology, products, and business model development.
SUNSHINE OIL (02012) plans to issue 98,494,300 shares at a discount of about 5% for debt-to-equity conversion.
CITIC SEC: The Federal Reserve's interest rate hike in September is a non-decisive variable, and the A-share market will remain dominated by fluctuations.
ZHIHU-W (02390) plans to invest 1.5 billion yuan to subscribe for limited partnership equity in a fund to deepen its understanding of the evolution of artificial intelligence technology, products, and business model development.
SUNSHINE OIL (02012) plans to issue 98,494,300 shares at a discount of about 5% for debt-to-equity conversion.
CITIC SEC: The Federal Reserve's interest rate hike in September is a non-decisive variable, and the A-share market will remain dominated by fluctuations.
RECOMMEND
